AnaptysBio, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 26.41 million compared to USD 32.54 million a year ago. Basic loss per share from continuing operations was USD 0.93 compared to USD 1.18 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.6 USD | +1.35% | -0.58% | +19.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.51% | 690M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022